Biomarker trajectory for earlier detection of lung cancer
This study was supported by NIH Grant Nos. U01CA271888, U01CA194733, U01CA213285, NCI EDRN U01 CA200468, P30CA016672, and U24CA086368; the Cancer Prevention & Research Institute of Texas RP180505 and RP160693; the SPORE P50CA140388; the CCTS TR000371; and the generous philanthropic contributions to The University of Texas MD Anderson Cancer Center Moon Shots Program and the Lyda Hill Foundation.
Authors
- Iakovos Toumazis (ORCID: https://orcid.org/0000-0002-3462-2137)
- Ehsan Irajizad (ORCID: https://orcid.org/0000-0001-7510-4849)
- Yu Shen (ORCID: https://orcid.org/0000-0002-3899-7868)
- Samir Hanash (ORCID: https://orcid.org/0000-0002-4210-1593)
- Jody V. Vykoukal (ORCID: https://orcid.org/0000-0001-7797-627X)
- Kim‐Anh Do (ORCID: https://orcid.org/0000-0001-8710-7131)
- Edwin J. Ostrin (ORCID: https://orcid.org/0000-0002-4538-6539)
- Ziding Feng (ORCID: https://orcid.org/0000-0003-3051-8882)
- Jennifer B. Dennison (ORCID: https://orcid.org/0000-0003-3067-0972)
- Johannes F Fahrmann
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105377
- Citations
- 6
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- Cancer Prevention and Research Institute of Texas
- Lyda Hill Foundation
- Center for Clinical and Translational Science, University of Illinois at Chicago
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute